SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-004564
Filing Date
2019-05-09
Accepted
2019-05-09 07:11:25
Documents
51
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q axsm-20190331x10q.htm 10-Q 1555608
2 EX-31.1 axsm-20190331ex3119ba834.htm EX-31.1 12065
3 EX-31.2 axsm-20190331ex312e6bcd2.htm EX-31.2 11289
4 EX-32.1 axsm-20190331ex3211ff736.htm EX-32.1 5894
5 EX-32.2 axsm-20190331ex322916f73.htm EX-32.2 5873
  Complete submission text file 0001558370-19-004564.txt   4334535

Data Files

Seq Description Document Type Size
6 EX-101.INS axsm-20190331.xml EX-101.INS 666359
7 EX-101.SCH axsm-20190331.xsd EX-101.SCH 33841
8 EX-101.CAL axsm-20190331_cal.xml EX-101.CAL 29075
9 EX-101.DEF axsm-20190331_def.xml EX-101.DEF 76217
10 EX-101.LAB axsm-20190331_lab.xml EX-101.LAB 313977
11 EX-101.PRE axsm-20190331_pre.xml EX-101.PRE 217036
Mailing Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038
Business Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37635 | Film No.: 19808752
SIC: 2834 Pharmaceutical Preparations